Winner Medical(SZ:300888) Sou Hu Cai Jing·2025-12-30 12:31Group 1 - The core viewpoint of the news is that Steady Medical (300888) has shown significant growth in its financial performance for the first three quarters of 2025, with a notable increase in revenue and net profit compared to the previous year [2] - For the first three quarters of 2025, the company's main revenue reached 7.897 billion yuan, representing a year-on-year increase of 30.1%, while the net profit attributable to shareholders was 732 million yuan, up 32.36% [2] - In Q3 2025 alone, the company reported a single-quarter main revenue of 2.601 billion yuan, which is a 27.71% increase year-on-year, and a net profit of 240 million yuan, reflecting a 42.11% increase [2] Group 2 - The company's debt ratio stands at 33.87%, with investment income of 33.23 million yuan and financial expenses of -2.036 million yuan, indicating a strong financial position [2] - The gross profit margin for Steady Medical is reported at 48.32%, showcasing the company's efficiency in managing costs relative to its revenue [2] - Over the past 90 days, 21 institutions have provided ratings for the stock, with 17 recommending a buy and 4 recommending an increase in holdings, while the average target price set by institutions is 5.488 billion yuan [2]